Identification |
Name: | 6H-Benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol,4a,5,9,10,11,12-hexahydro-11-methyl-, (4aS,6R,8aS)- |
Synonyms: | Galanthamine,O-demethyl-; 6H-Benzofuro[3a,3,2-ef][2]benzazepine-3,6-diol,4a,5,9,10,11,12-hexahydro-11-methyl-, [4aS-(4aa,6b,8aR*)]-; O-Demethylgalanthamine; Sanguinine |
CAS: | 60755-80-8 |
Molecular Formula: | C16H19 N O3 |
Molecular Weight: | 273.33 |
InChI: | InChI=1/C16H19NO3/c1-17-7-6-16-5-4-11(18)8-13(16)20-15-12(19)3-2-10(9-17)14(15)16/h2-5,11,13,18-19H,6-9H2,1H3/t11-,13-,16-/m0/s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 227.1°C |
Boiling Point: | 451.9°C at 760 mmHg |
Density: | 1.37g/cm3 |
Refractive index: | 1.683 |
Appearance: | Pale Yellow Powder |
Specification: | Pale Yellow Powder usageEng:A metabolite of Galanthamine, a selective acetylcholinesterase inhibitor |
Flash Point: | 227.1°C |
Usage: | A metabolite of Galanthamine, a selective acetylcholinesterase inhibitor |
Safety Data |
|
|